IFATS collection: Fibroblast growth factor-2-induced hepatocyte growth factor secretion by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism

Stem Cells

Volumn 27, Issue 1, 2009, Pages 238-249

  Suga, Hirotaka ^a   Eto, Hitomi ^a   Shigeura, Tomokuni ^b   Inoue, Keita ^a   Aoi, Noriyuki ^a   Kato, Harunosuke ^a   Nishimura, Satoshi ^a   Manabe, Ichiro ^a,c   Gonda, Koichi ^a   Yoshimura, Kotaro ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b Biomaster Inc   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adipose derived stem cells; c Jun N terminal kinase; Fibroblast growth factor 2; Fibrogenesis; Hepatocyte growth factor; Ischemia reperfusion injury

Indexed keywords

BROXURIDINE; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ADIPOSE TISSUE CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBROGENESIS; HUMAN; HUMAN CELL; INGUINAL REGION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; STROMA CELL; TISSUE INJURY; TISSUE REPAIR; UPREGULATION;

ADIPOSE TISSUE; ADULT; ANIMALS; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; INTRACELLULAR SPACE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; PHENOTYPE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STROMAL CELLS; WOUND HEALING;

EID: 59849096397     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0261     Document Type: Article

References (51)

1. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
2. Rehman J, Traktuev D, Li J et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292-1298.
3. Kilroy GE, Foster SJ, Wu X et al. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and proinflammatory factors. J Cell Physiol 2007;212:702-709.
4. Nakagami H, Maeda K, Morishita R et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005;25:2542-2547.
5. Planat-Benard V, Silvestre JS, Cousin B et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004;109:656-663.
6. Miranville A, Heeschen C, Sengenes C et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004;110:349-355.
7. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
8. Rodriguez AM, Pisani D, Dechesne CA et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 2005;201:1397-1405.
9. Matsumoto D, Sato K, Gonda K et al. Cell-assisted lipotransfer: Supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006;12:3375-3382.
10. Lendeckel S, Jodicke A, Christophis P et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J Craniomaxillofac Surg 2004;32:370-373.
11. García-Olmo D, Garcia-Arranz M, Herreros D et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48:1416-1423.
12. Yoshimura K, Sato K, Aoi N et al. Cell-assisted lipotransfer (CAL) for cosmetic breast augmentation: Supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 2008;32:48-55.
13. Chiou M, Xu Y, Longaker MT. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 2006;343:644-652.
14. Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 2006;12:1405-1418.
15. Kakudo N, Shimotsuma A, Kusumoto K. Fibroblast growth factor-2 stimulates adipogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun 2007;359:239-244.
16. Kang YJ, Jeon ES, Song HY et al. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J Cell Biochem 2005;95:1135-1145.
17. Suga H, Shigeura T, Matsumoto D et al. Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy 2007;9:738-745.
18. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 2001;410:37-40.
19. Wang M, Crisostomo PR, Herring C et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-1 in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006;291:R880-R884.
20. Aiba-Kojima E, Tsuno NH, Inoue K et al. Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: Comparison with platelet-rich plasma and potential use in cell culture. Wound Repair Regen 2007;15:511-520.
21. Akita S, Akino K, Imaizumi T et al. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns 2005;31:855-858.
22. Nakamura T, Mizuno S, Matsumoto K et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000;106:1511-1519.
23. Yoshimura K, Shigeura T, Matsumoto D et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006;208:64-76.
24. Suga H, Matsumoto D, Inoue K et al. Numerical measurement of viable and nonviable adipocytes and other cellular components in aspirated fat tissue. Plast Reconstr Surg 2008;122:103-114.
25. Nishimura S, Manabe I, Nagasaki M et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 2007;56:1517-1526.
26. Montesano R, Vassalli JD, Baird A et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 1986;83:7297-7301.
27. Nissen NN, Polverini PJ, Gamelli RL et al. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery 1996;119:457-465.
28. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A et al. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-840.
29. Schulze-Osthoff K, Risau W, Vollmer E et al. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 1990;137:85-92.
30. Takamiya M, Saigusa K, Aoki Y. Immunohistochemical study of basic fibroblast growth factor and vascular endothelial growth factor expression for age determination of cutaneous wound. Am J Forensic Med Pathol 2002;23:264-267.
31. Muthukrishnan L, Warder E, McNeil PL. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells. J Cell Physiol 1991;148:1-16.
32. Bashkin P, Doctrow S, Klagsburn M et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989;28:1737-1743.
33. Ishai-Michaeli R, Eldor A, Vlodavsky I. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul 1990;1:833-842.
34. Mori S, Matsuzaki K, Yoshida K et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004;23:7416-7429.
35. Rush S, Khan G, Bamisaiye A et al. C-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells. Exp Cell Res 2007;313:121-132.
36. Onimaru M, Yonemitsu Y, Tanii M et al. Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 2002;91:923-930.
37. Roletto F, Galvani AP, Cristiani C et al. Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. J Cell Physiol 1996;166:105-111.
38. Blanquaert F, Delany AM, Canalis E. Fibroblast growth factor-2 induces hepatocytes growth factor/scatter factor expression in osteoblasts. Endocrinology 1999;140:1069-1074.
39. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 1992;188:235-243.
40. Takami Y, Motoki T, Yamamoto I et al. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-γ. Biochem Biophys Res Commun 2005;327:212-217.
41. Wu YL, Gohda E, Iwao M et al. Stimulation of hepatocyte growth factor production by ascorbic acid and its stable 2-glucoside. Growth Horm IGF Res 1998;8:421-428.
42. Coban YK, Kurutas EB, Ciralik H. Ischemia-reperfusion injury of adipofascial tissue: An experimental study evaluating early histologic and biochemical alterations in rats. Mediators Inflamm 2005;2005:304-308.
43. Zengin E, Chalajour F, Gehling UM et al. Vascular wall resident progenitor cells: A source for postnatal vasculogenesis. Development 2006;133:1543-1551.
44. Traktuev D, Merfeld-Clauss S, Li J et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008;102:77-85.
45. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230.
46. Liu Y. Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 2004;287:F7-F16.
47. Yang J, Dai C, Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol 2003;163:621-632.
48. Bikfalvi A, Klein S, Pintucci G et al. Biological roles of fibroblast growth factor-2. Endocr Rev 1997;18:26-45.
49. Conway K, Price P, Harding KG et al. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen 2006;14:2-10.
50. Bell LN, Cai L, Johnstone BH et al. A central role for hepatocyte growth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 2008;294:E336-E344.
51. Cai L, Johnstone BH, Cook TG et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. STEM CELLS 2007;25:3234-3243.